SHERIDAN,Wyo.,March 17,2025-- GoEnhanceAI,a leading AI video generation platform,has launched its fourth-generation video-to-video technology,marking a major leap forward in AI-powered video creation.
The white paper sheds light on the growth and intelligent development trends of the robotic pool cleaning industry and highlights its core driving factors.
NEW YORK,March 17,2025-- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insights before
Global experts gather for in-depth discussions on key industry issues,unlocking ASEAN opportunities,AI and culture-driven marketing
SINGAPORE,March 18,2025-- Optty,a B Corp-certified global payments infrastructure platform,and ekko,a sustainability platform for banks and payments companies,are partnering to make it easier for bus
SINGAPORE,March 3,2025-- The global whisky market is changing. As consumer preferences evolve and new markets emerge,ultra age premium whiskies and whisky cask investment has become a profitable alter
SINGAPORE,Feb. 12,2025-- On 12 Feb 2025,Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administra
HONG KONG,Feb. 12,2025-- Today (12 February),in the second session of the "A Personal Perspective on Doing Good Research" seminar series organised by the School of Graduate Studies of Lingna
BridgingHeritage andGlobalInfluenceThroughCulture,Wellness,Gastronomy,andSustainability. BALI,Indonesia,Feb. 12,2025-- The Apurva Kempinski Bali is taking its commitment to celebrating Indonesia\'s ri
Transforming Lives with Clean Water HO CHI MINH CITY,Vietnam,Feb. 12,2025-- In a small rural village in southern Vietnam,access to clean water was once a distant dream. Families depended on rainwater
LOS ANGELES,Feb. 12,2025-- In an era where career shifts and lifestyle changes are increasingly common,furnishing a home is no longer a one-time endeavor. According to the U.S. Department of Labor,the
Confirms the utility of the 10 mg daily oral dose of Xanamem being studied in late-stage clinical trials in Alzheimer\'s disease and major depressive disorder